Fulcrum Therapeutics Stock Forecast

Stock Price Forecast

According to 7 professional analysts, the 12-month price target for Fulcrum Therapeutics stock ranges from a low of $2.00 to a high of $12. The average analyst price target of $6.29 forecasts a -11.66% decrease in the stock price over the next year.

Price Target: $6.29 (-11.66%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$2.00	$6.29	$4.00	$12
Change	-71.91%	-11.66%	-43.82%	+68.54%

Analyst Ratings

The average analyst rating for Fulcrum Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	1	1	1	1	1	0
Buy	2	2	2	2	2	3
Hold	6	6	5	5	5	3
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	10	10	9	9	9	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Maintains $6 → $9	Buy	Maintains	$6 → $9	+26.40%	May 29, 2025
Joseph Schwartz Leerink Partners	Leerink Partners	Hold → Buy Upgrades $4 → $12	Hold → Buy	Upgrades	$4 → $12	+68.54%	May 23, 2025
Kristen Kluska Cantor Fitzgerald	Cantor Fitzgerald	Hold → Buy Upgrades $10	Hold → Buy	Upgrades	$10	+40.45%	May 15, 2025
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $4	Hold	Reiterates	$4	-43.82%	Feb 26, 2025
Gregory Renza RBC Capital	RBC Capital	Hold Reiterates $4	Hold	Reiterates	$4	-43.82%	Nov 14, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 80.00M

Revenue Next Year

318.24K

EPS This Year

-1.18

from -0.16

EPS Next Year

-1.23

from -1.18

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	8.82M	19.16M	6.34M	2.81M	80.00M	-	318.24K	-
Revenue Growth	-	117.19%	-66.91%	-55.77%	2,752.05%	-	-	-
EPS	-2.79	-2.29	-2.44	-1.59	-0.16	-1.18	-1.23	-1.17
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	1.6M	n/a
Avg	n/a	318,240	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.14	-1.17	-1.05
Avg	-1.18	-1.23	-1.17
Low	-1.20	-1.28	-1.26

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.